Congress of European Crohn's and Colitis Organisation

Healio brings you the highlights from the Congress of European Crohn's and Colitis Organisation. Refer back to this page often for the latest news from ECCO, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News CoveragePerspective

Harm from prostate cancer screening may outweigh potential benefits

October 10, 2013
Although widespread screening for prostate cancer may prevent one death in every 1,000 men, the additional biopsies and treatment of low-risk…
Meeting News Coverage

Cediranib plus chemotherapy prolonged PFS, OS in ovarian cancer

October 9, 2013
The addition of cediranib to chemotherapy significantly improved PFS in patients with recurrent ovarian cancer, according to results of an…
Meeting News CoveragePerspective

Diabetes increased risk for breast, colorectal cancers

October 8, 2013
Patients with diabetes were at increased risk for breast and colorectal cancer incidence and mortality, according to results of a pooled…
Meeting News Coverage

12-gene assay predicted risk for rectal cancer recurrence

HemOnc Today, November 10, 2013
The Oncotype DX Recurrence Score more accurately predicted risk for local recurrence, distant recurrence and rectal cancer-specific survival in…
Meeting News Coverage

12-gene assay predicted risk for rectal cancer recurrence

October 4, 2013
The Oncotype DX Recurrence Score more accurately predicted risk for local recurrence, distance recurrence and rectal cancer-specific survival in…
Meeting News Coverage

Zelboraf linked to antitumor activity in BRAF-mutated papillary thyroid cancer

HemOnc Today, November 10, 2013
Vemurafenib was associated with antitumor activity in treatment-naive and tyrosine kinase inhibitor-pretreated patients with radioactive iodine…
Meeting News Coverage

Zelboraf linked to antitumor activity in BRAF-mutated papillary thyroid cancer

October 3, 2013
Vemurafenib was associated with antitumor activity in treatment-naive and tyrosine kinase inhibitor-pretreated patients with radioactive iodine…
Meeting News Coverage

Sorafenib benefited patients with RAS, BRAF mutations

HemOnc Today, November 10, 2013
Regardless of the presence of a BRAF or RAS mutation, patients who received sorafenib demonstrated improved PFS when compared with placebo…
Meeting News Coverage

Sorafenib benefited patients with RAS, BRAF mutations

October 2, 2013
Regardless of the presence of a BRAF or RAS mutation, patients who received sorafenib demonstrated improved PFS when compared with placebo…
Meeting News CoveragePerspective

Nodal radiation therapy improved breast cancer outcomes

September 29, 2013
Postoperative radiation therapy to the internal mammary and medial supraclavicular lymph nodes extended survival in patients with lymph node-involved…
Healio Jobs